Evidence map›Paper›PMID 42287468›Full record

ArticleEuropean journal of nutrition2026

Consumption of whole and refined grains and the risk of gastric cancer: a pooled analysis within the Stomach cancer Pooling (StoP) Project.

Federica Turati, Francesca Bravi, Claudio Pelucchi, Rossella Bonzi, Kenneth C Johnson, Jinfu Hu, Monica Ferraroni, Zuo Feng Zhang, Guopei Yu, Nuno Lunet and 25 more

Abstract read
In one paragraph

Article in European journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Federica TuratiDepartment of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano, via Celoria 22, Milan, 20133, Italy.
Francesca BraviDepartment of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano, via Celoria 22, Milan, 20133, Italy. francesca.bravi@unimi.it.ORCID http://orcid.org/0000-0003-0173-5319
Claudio PelucchiDepartment of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano, via Celoria 22, Milan, 20133, Italy.
Rossella BonziDepartment of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano, via Celoria 22, Milan, 20133, Italy.
Kenneth C JohnsonSchool of Epidemiology and Public Health, Department of Medicine, University of Ottawa, Ottawa, Canada.
Jinfu HuHarbin Medical University, Harbin, China.
Monica FerraroniDepartment of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano, via Celoria 22, Milan, 20133, Italy.
Zuo Feng ZhangDepartment of Epidemiology, UCLA Fielding School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
Guopei YuMedical Informatics Center, Peking University, Peking, China.
Nuno LunetEPIUnit ITR, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal.
Samantha MoraisEPIUnit ITR, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal.
David ZaridzeDepartment of Clinical Epidemiology, N.N.Blokhin National Medical Research Center for Oncology, Moscow, Russia.
Dmitry MaximovitchDepartment of Clinical Epidemiology, N.N.Blokhin National Medical Research Center for Oncology, Moscow, Russia.
Jesus VioqueInstituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernandez (ISABIAL-UMH), Alicante, Spain.
Sandra Gonzalez-PalaciosInstituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernandez (ISABIAL-UMH), Alicante, Spain.
Maria Paula CuradoCentro Internacional de Pesquisa, A. C. Camargo Cancer Center, São Paulo, Brazil.
Emmanuel Dias-NetoRutgers Cancer Institute, Rutgers University, Newark, NJ, USA.
Gemma Castaño-VinyalsConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Nerea Fernández de Larrea-BazConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Lizbeth López-CarrilloNational Institute of Public Health, Morelos, Mexico.
Raul Ulises Hernández-RamirezDepartment of Biostatistics, Yale School of Public Health, Yale School of Medicine, New Haven, CT, USA.
Shoichiro TsuganeDivision of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Gerson Shigueaki HamadaNikkei Disease Prevention Center, São Paulo, Brazil.
Mary H WardDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Lina MuDepartment of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA.
Charles S RabkinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Akihisa HidakaDivision of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Areti LagiouDepartment of Public and Community Health, School of Public Health, University of West Attica, Athens, Greece.
Pagona LagiouDepartment of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Malaquias López-CervantesFacultad de Medicina, UNAM, Coyoacán, Mexico.
Paolo BoffettaDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
M Constanza CamargoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Stefania BocciaUniversity Department of Life Sciences and Public Health, Section of Hygiene, Università Cattolica del Sacro Cuore, Roma, Italy.
Eva NegriDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Carlo La VecchiaDepartment of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano, via Celoria 22, Milan, 20133, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe relationship between whole and refined grain intake and gastric cancer risk has been investigated, but findings remain inconclusive. We aimed to evaluate and quantify the association of whole and refined grain consumption with gastric cancer risk through an individual participant pooled analysis of studies participating in the Stomach cancer Pooling (StoP) Project.

methodsTwenty case-control studies (including 7,943 cases and 19,729 controls) contributed to the analysis of refined grains, and 13 of these (5,658 cases and 15,802 controls) contributed to the analysis of whole grains. Study-specific odds ratios (ORs) were estimated using multivariable logistic regression models and pooled through a two-stage approach based on fixed-effects models.

resultsFor whole grains, compared with no consumption, the OR was 0.92 (95% confidence interval, CI: 0.84-1.01) for any consumption, and 0.86 (95% CI: 0.77-0.96) for a consumption equal or above the study-specific median. There was an increasing risk of gastric cancer with increasing consumption of refined grains, with an OR for the highest versus the lowest tertile of 1.39 (95% CI: 1.28-1.50) when considering staple grain foods only and 1.52 (95% CI: 1.39-1.65) when also considering grain-based sweets and desserts.

conclusionOur findings indicate that whole grain consumption is inversely associated, and refined grain consumption directly associated with gastric cancer risk. These findings support current dietary recommendations favoring whole grains over refined grains.

Indexed as

DietEdible GrainStomach NeoplasmsWhole GrainsAgedCase-Control StudiesFemaleHumansMaleMiddle AgedOdds RatioRisk FactorsCase-control studiesConsortiumDietGastric cancerPooled analysis

Identifiers

PMID42287468
PMCPMC13264596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.